Description
Vesugen 20 mg: Product Description
Vesugen is a synthetic bioregulator tripeptide with the amino acid sequence Lys-Glu-Asp (KED) (Wikipedia, 2026). It is classified as a vascular-specific peptide, originally developed to study and potentially modulate the functional state of the vascular system (Khavinson & Tarnovskaya, 2015).
Key Research Properties
-
Target Tissue: Specifically interacts with vascular endothelial cells and cardiovascular tissues (Khavinson & Tarnovskaya, 2015).
-
Mechanism of Action: Preliminary research suggests that Vesugen may penetrate cell nuclei and site-specifically interact with gene promoter regions (Khavinson & Tarnovskaya, 2015). Specifically, it has been observed to stimulate the expression of the Ki-67 protein, a marker of cell proliferation, which typically decreases during cellular aging (Khavinson & Tarnovskaya, 2015).
-
Biological Implications: In laboratory models, the peptide has been studied for its potential to:
-
Protect the vascular system from age-related degradation and endothelial dysfunction (IndiaMART, 2024).
-
Influence cellular regeneration and protein synthesis in fibroblast-derived neurons (PMC, 2024).
-
Improve parameters related to atherosclerosis and hypertensive conditions in experimental subjects (Khavinson & Tarnovskaya, 2015).
-
Technical Specifications
-
Sequence:
-
Molecular Formula: (Wikipedia, 2026)
-
Molar Mass: (Wikipedia, 2026)
-
Format: Typically supplied as a lyophilized powder for reconstitution.
Intended Use
For Research Use Only. This product is intended solely for laboratory research and in vitro studies. It is not intended for human or animal consumption, diagnostic procedures, or therapeutic use.
